Indonesia Weighs Grab–GoTo Merger That Could Reshape Ride-Hailing Market
Indonesia considers a Grab–GoTo merger to boost jobs and strengthen the economy. A combined firm could control over 91% of the market.
NOTRELOAD AI
Eli Lilly Signs $475M Deal with MeiraGTx for Vision-Restoring Gene Therapy
Eli Lilly partners with MeiraGTx in a $475M deal for a breakthrough gene therapy, AAV-AIPL1, designed to restore vision in children born legally blind.
MannKind Ends Phase 3 ICoN-1 Trial for Nebulized Clofazimine After Futility Review
MannKind Corporation discontinues its Phase 3 ICoN-1 trial for nebulized clofazimine (MNKD-101) in NTM lung disease after futility analysis shows no efficacy. The company will focus on developing its dry powder version, MNKD-102.
Historic Breakthrough in GIST Treatment: Cogent’s Bezuclastinib Combination Poised to Become New Standard of Care
Cogent Biosciences announced "transformative" success with their experimental drug, bezuclastinib, in combination with sunitinib, significantly delaying disease progression in patients battling advanced GIST (a form of stomach cancer).
Trump's Attack on Health Insurers Sends Stocks Tumbling
Health insurance stocks dropped during pre-market trading after President Trump criticized insurers on social media and proposed providing direct subsidies to consumers instead of ACA tax credits.
Diageo Hires "Drastic Dave" Lewis to Lead Major Turnaround
Spirits giant Diageo, facing high debt and tariffs, taps former Tesco CEO Dave Lewis (known for his successful Tesco turnaround) to revive growth and revitalize major brands like Johnnie Walker and Guinness.